Parisa Razaz

Parisa Razaz is a prominent professional in the field of therapeutics, currently serving as the Founder and CEO of Kumuda, a company focused on accelerating the discovery and development of novel treatments for patients.

With a background as a multidisciplinary scientist and computational biologist, Parisa has a proven history of leading successful projects and possesses a profound understanding of drug discovery and development, drawing from over a decade of experience in academia, consultancy, and biotech.

Her expertise lies in integrating knowledge from various fields and utilizing multi-omic datasets to uncover new biological insights.

Parisa's educational journey includes a Postdoctoral Research in Neurodevelopmental Genomics from Harvard University, a PhD in Computational Biology with a focus on Cancer Research from The Institute of Cancer Research, a Master of Arts in Natural Sciences from the University of Cambridge, an MSc in Molecular Medicine from Imperial College London, and a Bachelor's degree in Natural Sciences specializing in Biochemistry from the University of Cambridge.

Her professional experience encompasses roles such as Postdoctoral Researcher at the Broad Institute of MIT and Harvard, Drug Target Analyst at Exscientia, Board Member at the Institute of Cancer Research, Life Science Research Consultant at Deallus Group, and Business Development Assistant at Actant.

Parisa Razaz's leadership at Kumuda and her extensive background in the pharmaceutical and biotech sectors position her as a thought leader and innovator in the industry.